Page 6 - உலகளாவிய ஆரோக்கியம் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vancouver, Wash. biotech company Absci files to go public July 1, 2021 at 8:36 am Absci CEO and founder Sean McClain. (Absci Photo) Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built to design and generate protein-based drug candidates and help screen them for optimal functioning. The announcement follows a string of acquisitions and funding rounds for the company. This month the company acquired the synthetic biology company Totient, following its January acquisition of Denovium, a small deep learning startup capable of analyzing the function and behavior of proteins.

United statesBritish columbiaSean mcclainSujal patelExchange commissionIsilon systemsMerck global health innovation fundAbsci photoGlobal health innovationXyphos biotechnologyAlpha cancer technologiesVenture partnersSana biotechnologyImpel neuropharmaSeattle based nautilus biotechnologyஒன்றுபட்டது மாநிலங்களில்